Testing newborns for type 1 diabetes risk
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at infants to find how likely they are to develop type 1 diabetes later in life. If you have a newborn who is very young, you may be able to take part by allowing the study team to test them as part of early risk screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be no older than 6 weeks old
- A parent or legal guardian must agree and sign consent forms
- You must be able to bring your baby for the study testing visits
- You must be available to follow the study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens newborn babies (up to 6 weeks old) to identify those at high risk for type 1 diabetes, so they can be invited to join future prevention trials. The goal is to catch risk early and potentially prevent the disease.
This study checks for specific blood markers (“islet autoantibodies”) to find children who may be at risk for developing type 1 diabetes later, before symptoms start. It’s mainly for children who have no known diabetes yet.
This study screens children aged 2 to 10 for early signs of type 1 diabetes using a simple blood test. Finding these signs early may help prevent or delay the disease.
This study tests whether a program of diet and activity advice for families can lower the risk of type 1 diabetes in infants who have a higher genetic chance of developing it. It aims to find simple, everyday ways to help protect your child.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
This study looks at immune system cells and gene activity in infants and young children to understand what causes type 1 diabetes to start so early. It may help researchers find earlier warning signs and better ways to support families right at diagnosis.
Hear when a new Identification of Infants at Risk for Type 1 Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.